LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Acrivon Therapeutics (NASDAQ: ACRV)

Follow NASDAQ:ACRV Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ACRV Acrivon Therapeutics
Miller Mary / officer: Chief Legal Officer
04/01/2025
Buy
$1.68
15,616
$26K
15,616
NASDAQ ACRV Acrivon Therapeutics
Levy Adam D. / officer: Chief Financial Officer
04/01/2025
Buy
$1.68
35,209
$59K
35,209
NASDAQ ACRV Acrivon Therapeutics
Levy Adam D. / officer: Chief Financial Officer
04/01/2025
Sell
$11.26
43,425
$489K
0
NASDAQ ACRV Acrivon Therapeutics
Levy Adam D. / officer: Chief Financial Officer
04/01/2025
Sell
$5.70
38,500
$219K
0
NASDAQ ACRV Acrivon Therapeutics
Levy Adam D. / officer: Chief Financial Officer
04/01/2025
Sell
$5.31
74,100
$393K
0
NASDAQ ACRV Acrivon Therapeutics
Peterson Katharine / officer: Chief Accounting Officer
03/01/2025
Buy
$5.31
31,900
$169K
31,900
NASDAQ ACRV Acrivon Therapeutics
Miller Mary / officer: Chief Legal Officer
03/01/2025
Buy
$5.31
93,693
$498K
93,693
NASDAQ ACRV Acrivon Therapeutics
Holm-Jorgensen Rasmus / officer: Chief Financial Officer
03/01/2025
Buy
$5.31
109,309
$580K
109,309
NASDAQ ACRV Acrivon Therapeutics
Gamelin Erick / officer: Chief Development Officer
03/01/2025
Buy
$5.31
78,078
$415K
78,078
NASDAQ ACRV Acrivon Therapeutics
Devroe Eric / officer: Chief Operating Officer
03/01/2025
Buy
$5.31
140,540
$746K
140,540
NASDAQ ACRV Acrivon Therapeutics
Cuillerot Jean-Marie / officer: Chief Medical Officer
03/01/2025
Buy
$5.31
78,078
$415K
78,078
NASDAQ ACRV Acrivon Therapeutics
Blume-Jensen Peter / director, officer: President and CEO
03/01/2025
Buy
$5.31
390,390
$2.073M
390,390
NASDAQ ACRV Acrivon Therapeutics
Blume-Jensen Peter / director, officer: President and CEO
03/01/2025
Buy
$5.31
140,540
$746K
140,540
NASDAQ ACRV Acrivon Therapeutics
Blume-Jensen Peter / director, officer: President and CEO
02/21/2025
Sell
$5.54
19,904
$110K
2.29M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous